Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) Study 2.0 - An FNIH Biomarkers Consortium Study

NCT07122700 is registered in ClinicalTrials.gov with Foundation for the National Institutes of Health as lead sponsor.

NCT NCT07122700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) Study 2.0 - An FNIH Biomarkers Consortium Study
Lead sponsor
Foundation for the National Institutes of Health
Phase
Observational
Overall status
Recruiting
Start date
May 13, 2025
Completion date
July 31, 2026
Enrollment
400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, liver fat, liver fibrosis, liver inflammation, liver steatoses, metabolic associated fatty liver disease, metabolic associated steatotic liver disease, nash